Lifera Email Formats

Pharmaceutical Manufacturing • Al Woroud, Riyadh, Saudi Arabia • 21-50 Employees

Lifera Email Formats

Lifera uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@lifera.com.sa), used 55.6% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@lifera.com.sa	55.6%
{first initial}{last name}	jdoe@lifera.com.sa	29.6%
{last name}{last name}	doedoe@lifera.com.sa	14.8%

Key Contacts at Lifera

Rawan Alghamdi

Director Of Procurement

Turki Aljlajel

Government Partnerships Director

Nisreen Qaid

Director Of Communications

Abdullah Rajkhan

Director, Risk & Compliance

Ahmed Alhamad

Director Of Regulatory Affairs

Guillermo Macarron

Strategy Director ■ Corporate Strategy | Investment | Strategic Alliances | Go-To-Market

Junaid Raja

Director Of Operations

Jacob Hallengreen

Program Director

Sarah Hallengreen

Adm. Program Assistant & Ea To The Program Director

Company overview

Headquarters	Al Woroud, Riyadh, Saudi Arabia
Website	lifera.com.sa
NAICS	3254
Keywords	Insulin, Vaccines, Biomanufacturing, Plasmids, Genomic Testing, Multiomics, Cell And Gene Therapy, Nucleic Acids, Sterile Injectables, Plasma Therapeutics
Founded	2023
Employees	21-50
Socials

About Lifera

Lifera is a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) with a mission to enable two national priority objectives, which are improving Saudi Arabia’s biopharma resilience, and enabling the achievement of the National Biotech Strategy. To achieve this mission, Lifera aims to become a leading biopharma Contract Development and Manufacturing Organization (CDMO) with a focus on advanced therapeutics and critical medicines. Lifera’s strategy is to be a service provider to biopharma and biotech companies globally by developing and acquiring state-of-the-art cGMP biomanufacturing capacity, establishing high throughput multi-omics capacity to support clinical, population health and R&D customers, securing high-value commercial partnerships and technology transfer, and developing a high caliber biopharma workforce. Lifera serves customers for both KSA and global markets through contract manufacturing of biologics including insulin, vaccines, monoclonal antibodies, gene therapies, and other advanced medicinal products, as well as through genetic testing services with a global presence and depth in rare disease with plans to expand into other therapeutic areas.